INVESTORS

INVESTORS

Corporate Profile

Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programsRead More

Stock Information

Copyright West LLC. Minimum 15 minutes delayed.

Stock Chart


Print Page  | RSS Feeds  | E-mail Alerts  | IR Contacts